CTP 347

Drug Profile

CTP 347

Alternative Names: CTP-347

Latest Information Update: 25 Jun 2013

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Concert Pharmaceuticals
  • Class Organic deuterium compounds; Piperidines; Small molecules
  • Mechanism of Action Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Hot flashes

Most Recent Events

  • 25 Jun 2013 Discontinued - Phase-I for Hot flashes in USA prior to 25 June 2013 (PO)
  • 14 Sep 2009 Final pharmacokinetics data from a phase I trial in Hot flashes released by Concert Pharmaceuticals
  • 16 Mar 2009 Interim pharmacokinetics and safety data from a phase I trial in healthy volunteers released by Concert Pharmaceuticals
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top